Summary
The global biotechnology industry in 2006 stood at USD73.12 billion up by 15.49% compared to 2005, the industry fared well in terms of fund raising, increased number of alliances and IPOs raised in the same period.Research and development activity, which is the foundation of success for the industry, is receiving continuous support all across the world with total R&D spend contributing to almost 38% of industry revenues.The revenue of the Indian biotechnology industry reached INR85.41billion in 2006-07, up 30.98% from INR 65.21 billion in 2005-06. In 2006-07, top Ten Indian Companies reported revenue of INR 37.74 billion.The biotechnology industry is highly research and development (R&D) intensive.Globally,about 37.9% of revenue is spent on finding and developing new products.
Although data relating to biotech R&D in India is not available, anecdotal evidence suggests that major companies are spending considerable amounts on biotech R&D, following their newfound focus on biotechnology. The Report on indian biotechnology gives information on the core technologies in biotechnology with reference to bio processing,monoclonal antibody,bio-nanotechnology etc. Indian biotechnology report describes major clusters region wise.It provides information on the regulatory bodies and the regulations in biotech industry along with the regulatory structure.It helps in knowing the critical success factors in biotechnology industry with reference to mergers & Acquisitions,product portfolio etc.At the end the report gives a future outlook for biotechnology industry.
|
